Practices
Industries

Changes In Regulatory Framework for Dietary Supplements in Russia: What Is to Be Expected?

24 July 2024

On 9 July 2024, the State Duma passed Bill No. 638771-8 “On Introduction of the Draft Federal Law ’On Amendments to Certain Legislative Acts of the Russian Federation’” (the “Bill”) in first reading, which focuses on changes in the regulatory regime for the circulation of dietary supplements in Russia.

The proposed amendments would introduce significant changes affecting the circulation of dietary supplements and, to a certain extent, bringing it closer to the regime established for pharmaceuticals and medical devices.

Natalya Thotahewage, Counsel in Lidings Life Sciences Industry Practice, Spoke at Largest Ophthalmology Conference

22 April 2024

On April 19, Moscow hosted the largest conference in the field of ophthalmology “Ophthalmology 360°. Health care, marketing, digitalization, law", which brought together leading industry experts: practicing ophthalmologists, representatives of regulatory bodies in the field of health care, specialists in the field of medical law and marketing.

The Pharma Legal Handbook: Russia 

13 April 2024

Lidings experts have authored the The Pharma Legal Handbook — practical directory focused on the key aspects of legislative regulation of pharmaceutical industry in Russia. The Handbook covers major issues linked to regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks and patents in Russia and is a must-have for any company operating in the country or looking to enter the market.

Lidings is a Strategic Partner of the "Pharmaceuticals 2024: Legal Issues" Conference, Pravo.ru

11 April 2024

On April 11, 2024, in Moscow, the annual Pravo.ru conference "Pharmaceuticals – 2024: Legal Issues" will take place. Lidings lawyers traditionally take an active part in the event’s program.

As a strategic partner of the conference, we have endeavored to make the program as comprehensive and useful as possible. Together with experts from the pharmaceutical industry and legal experts, we will discuss current issues in industry regulation, legislative changes, market access, government procurement, and distribution. We will also touch upon marketing and promotion issues, as well as discuss strategies for protecting intellectual property.